These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 2-H- and 2-acyl-9- [omega-[4-(2-methoxyphenyl)piperazinyl]-alkyl]-1,2,3,4-tetrahydro-beta-carbolines as ligands of 5-HT1A and 5-HT2A receptors. Boksa J, Mokrosz MJ, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A, Wesołowska A, Misztal S. Pol J Pharmacol; 2001; 53(5):501-8. PubMed ID: 11990069 [Abstract] [Full Text] [Related]
4. Synthesis, in vitro and in vivo 5-HT1A/5-HT2A serotonin receptor activity of new hybrid 1,2,3,4-tetrahydro-gamma-carbolines with 1-(2-methoxyphenyl)piperazine moiety. Boksa J, Charakchieva-Minol S, Duszyńska B, Bugno R, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E, Bojarski AJ. Pol J Pharmacol; 2003; 55(6):1013-9. PubMed ID: 14730096 [Abstract] [Full Text] [Related]
8. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione. Chloń G, Pawłowski M, Duszyńska B, Szaro A, Tatarczńska E, Kłodzińska AL, Chojnacka-Wójcik E. Pol J Pharmacol; 2001 Apr; 53(4):359-68. PubMed ID: 11990082 [Abstract] [Full Text] [Related]
10. Effect of the amide fragment on 5-HT1A receptor activity of some analogs of MP 3022. Paluchowska MH, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A. Pol J Pharmacol; 1999 Apr; 51(5):415-21. PubMed ID: 10817542 [Abstract] [Full Text] [Related]
11. Structure-activity relationship studies of CNS agents. Part 14: Structural requirements for the 5-HT1A and 5-HT2A receptor selectivity of simple 1-(2-pyrimidinyl)piperazine derivatives. Mokrosz JL, Strekowski L, Duszyńska B, Harden DB, Mokrosz MJ, Bojarski AJ. Pharmazie; 1994 Nov; 49(11):801-6. PubMed ID: 7838864 [Abstract] [Full Text] [Related]
12. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity. Mokrosz MJ, Kowalski P, Kowalska T, Majka Z, Duszyńska B, Charakchieva-Minol S, Szaro A, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E. Pol J Pharmacol; 1998 Nov; 50(4-5):333-40. PubMed ID: 10091718 [Abstract] [Full Text] [Related]
14. Structure-activity relationship studies of CNS agents. Part VIII. Bulk tolerance around the protonation center of 4-substituted 1-(3-chlorophenyl)piperazines at 5-HT1A and 5-HT2 receptors. Mokrosz JL, Charakchieva-Minol S, Paluchowska MH, Cegła MT. Pol J Pharmacol Pharm; 1992 Nov; 44(6):595-607. PubMed ID: 1305959 [Abstract] [Full Text] [Related]
17. Synthesis and 5-HT1A/5-HT2A activity of some butyl analogs in the group of phenylpiperazine alkyl pyrimido[2,1-f]theophyllines. Kołaczkowski M, Zajdel P, Fhid O, Duszyńska B, Tatarczyńska E, Pawłowski M. Pharmacol Rep; 2005 Nov; 57(2):229-35. PubMed ID: 15886422 [Abstract] [Full Text] [Related]
18. Substituted phenoxyalkylpiperazines as dopamine D3 receptor ligands. Laszlovszky I, Acs T, Kiss B, Domány G. Pharmazie; 2001 Apr; 56(4):287-9. PubMed ID: 11338664 [Abstract] [Full Text] [Related]